Related Experiment Video
Updated: May 19, 2026
07:43
Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
Published on: August 5, 2021
Proliferative vitreoretinopathy: current and emerging treatments
Ama Sadaka1, Gian Paolo Giuliari
1Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA, USA.
Clinical Ophthalmology (Auckland, N.Z.)
|September 4, 2012
Summary
Proliferative vitreoretinopathy (PVR) involves cell proliferation causing retinal detachment complications. Understanding PVR
Area of Science:
- Ophthalmology
- Retinal Diseases
- Cell Biology
Background:
- Proliferative vitreoretinopathy (PVR) is a major cause of vision loss after rhegmatogenous retinal detachment.
- Current surgical treatments for PVR have limitations, including high rates of redetachment and persistent vision impairment.
Purpose of the Study:
- To review the current understanding of PVR pathogenesis.
- To highlight novel treatment strategies based on molecular insights.
Main Methods:
- Literature review of studies on PVR pathogenesis.
- Analysis of the interplay between cytokines, growth factors, matrix proteins, and cells in PVR.
Main Results:
- PVR involves the proliferation of ectopic cell sheets leading to periretinal membrane formation and traction.
- An intricate interplay of cytokines, growth factors, matrix proteins, and cells drives PVR membrane formation.
Conclusions:
- Fundamental understanding of PVR's biochemical and molecular events is crucial for developing new therapies.
- Targeting cellular events in PVR pathogenesis offers promise for improved treatment outcomes.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...